Profitability Metrics

Gross Margin
36.92%
Operating Margin
30.73%
Net Margin
35.43%

Efficiency Metrics

Revenue per Expense Ratio
1.44
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
73.94%
Income Tax Rate
21.62%
EPS
10.8500000000

Balance Sheet Analysis

Current Ratio
2.61
Cash Ratio
1.43
Working Capital
$23.77B
Debt to Equity
1.84
Debt to Assets
57.23%
Equity Ratio
31.12%

Cash Flow Analysis

Operating Cash Flow Ratio
43.67%
Free Cash Flow Ratio
-0.50%
CapEx to Revenue
44.16%
Dividends Paid
$192.53M
Stock Buybacks
$880.91M
Total Shareholder Returns
$1.07B
Cash Position Change
-12.20%

Key Takeaways (2023 FY)

  • Revenue declined by 20.219104409537%, indicating potential market challenges

Detailed Growth Metrics

Core Performance

Revenue
-20.22%
Net Income
-39.76%
EPS
-38.28%
Operating Income
-45.03%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
-17.75%
Operating Cash Flow
-19.99%
Free Cash Flow
-103.55%

Balance Sheet Health

Assets
7.80%
Debt
3.29%
Book Value per Share
38.50%
Inventory
3.82%

Shareholder Returns

Dividends per Share
-95.25%
Shares Outstanding
-2.45%

Long Term Trends

3Y Revenue/Share
35.70%
5Y Revenue/Share
149.19%
3Y Dividend/Share
0.00%
5Y Dividend/Share
-22.82%